Results 51 to 60 of about 16,213 (203)

Liposomal amphotericin B for the treatment of visceral leishmaniasis

, 2006
During the past decade, liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). The World Health Organization convened a workshop to review current knowledge and to develop guidelines for liposomal ...
Rosenthal, E., Alvar, Jorge, den Boer, Margriet, Alvar, J., Davidson, Robert N., Figueras, Concepcion, Adler-Moore, J., Berenguer, Juan, Bern, C., den Boer, M., Berenguer, J., Sundar, Shyam, Saravolatz, Louis D., Boelaert, M., Boelaert, Marleen, Bern, Caryn, Davidson, R. N., Royce, C., Figueras, C., Russo, Rosario, Russo, R., Rosenthal, Eric, Kafetzis, Dimitris A., Royce, Catherine, Gradoni, L., Adler-Moore, Jill, Ritmeijer, Koert, Kafetzis, D. A., Gradoni, Luigi, Ritmeijer, E., Sundar, S.   +30 more
core   +1 more source

Epidemiology and Outcomes of Cryptococcal Infections in Liver Transplant Recipients: A Retrospective Cohort Study at a US Academic Center

Transplant Infectious Disease, EarlyView.
Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler, Chloe Hanigan, Atikur Rahman, Isuru Ratnayake, Phani Akella, Lauren Carlini, Chelsea Gorsline, Erica Mackenzie, Albert Eid, Dennis Shoemaker, Ryan Taylor, Stephen Waller   +11 more
wiley   +1 more source

Comparison between liposomal formulations of amphotericin B

, 2016
International audienceGiven the clinical success of commercial amphotericin B lipid products, investigators have begun making generic formulations of liposomal amphotericin B.
Adler-Moore, Jill P., Gangneux, Jean-Pierre, Pappas, Peter G   +2 more
core   +1 more source

Cutaneous Mucormycosis Clinically Mimicking Necrotizing Fasciitis in a Patient Without Active Immunosuppression

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Cutaneous mucormycosis is a rare invasive fungal infection caused by fungi of the order Mucorales. Although it classically occurs in immunocompromised hosts, traumatic or minor cutaneous inoculation may result in infection even in patients without active immunosuppression.
Akın Öğünç İnan, Nursel Yıldız Zengin, Anıl Pehlevan, Ender Ceylan, Güliz Uyar Güleç, Serkan Öncü   +5 more
wiley   +1 more source

Eventos adversos e custo da terapia com anfotericina B [PDF]

, 2012
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2010A toxicidade da Anfotericina B - desoxicolato (ABDOC) tem sido a maior limitante de sua utilização ...
Moresco, Gelcimar
core  

Liposomal Amphotericin B (AmBisome) Treatment Schedule.

, 2013
Liposomal Amphotericin B (AmBisome) Treatment Schedule.
Joris Veltman (431438), Jordan Dimitrakoff (431442), Adam P. Fagin (147181), Theo S. Plantinga (164719), Emeric F. Bojarski (431436), Mihai G. Netea (105648), Alexander Hoischen (195016), Adam C. Strauss (431437), Victor J. Anciano Granadillo (431440), Stephen A. Allsop (431439), Arsani William (431441)   +10 more
core   +1 more source

Disseminated Histoplasmosis: An Unusual Finding at ROSE

Diagnostic Cytopathology, Volume 54, Issue 6, Page E146-E148, June 2026.
ABSTRACT We describe an unusual case in which disseminated histoplasmosis was suspected at the time of of rapid on‐site assessment (ROSE) performed during endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA). The patient was a renal transplant recipient with fever, mild anemia, bilateral lung infiltrates and mediastinal ...
Erika E. Doxtader, Jona Banzon, Sanjay Mukhopadhyay   +2 more
wiley   +1 more source

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

, 2010
Background: Some 50% of patients with visceral leishmaniasis (kala-azar) worldwide live in the Indian state of Bihar. Liposomal amphotericin B is an effective treatment when administered in short courses.
Chakravarty, Jaya, Rai, Madhukar, Murray, Henry W., Sundar, Shyam, Agarwal, Dipti   +4 more
core   +1 more source

Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B

, 2021
OBJECTIVES: Liposomal amphotericin B is widely used to treat life-threatening invasive fungal infections and has replaced conventional amphotericin B deoxycholate due to its more favourable toxicity profile. Despite the fact that liposomal amphotericin B
Daele, R. Van, Bruggemann, Roger J., Brüggemann, R.J.M., Spriet, Isabel, Van Daele, Ruth, Maertens, J., de Beer, Yvo, Aarnoutse, Rob, Maertens, Johan, Beer, Y. de, Wauters, J., Croes, S., Aarnoutse, R.E., Spriet, I., Croes, Sander, Wauters, Joost   +15 more
core   +1 more source

Clinical and laboratory evaluation of patients with visceral leishmaniasis undergoing different therapeutic regimens of liposomal amphotericin B

Acta Scientiarum. Health Sciences
Visceral Leishmaniasis (VL) is an infectious disease caused by protozoa of the Leishmania genus and is transmitted to humans by the bite of infected female Lutzomyia sandflies.
Fernanda Santana da Silva, Elder Andrade Oliveira Filho , Maria Luísa Santos Fernandes, Gabriel Donner Oliveira, Victor Hugo Dantas Guimarães   +4 more
doaj   +1 more source